GSK US news http://www.us-gsk.com/html/media-news/ GlaxoSmithKline is a leading healthcare company that helps people to do more, feel better and live longer. This RSS feed contains press releases and investor news. GSK results announcement for Q4 and full year 2011 Tue, 07 Feb 2012 11:49:16 GMT http://www.us-gsk.com/html/media-news/pressreleases/2012/2012-pressrelease-892239.htm http://www.us-gsk.com/html/media-news/pressreleases/2012/2012-pressrelease-892239.htm GSK joins new global partnership to help defeat ten neglected tropical diseases by 2020 Mon, 30 Jan 2012 10:24:27 GMT http://www.us-gsk.com/html/media-news/pressreleases/2012/2012-pressrelease-875501.htm http://www.us-gsk.com/html/media-news/pressreleases/2012/2012-pressrelease-875501.htm GSK announces changes to the Board Fri, 27 Jan 2012 11:07:11 GMT http://www.us-gsk.com/html/media-news/pressreleases/2012/2012-pressrelease-871338.htm http://www.us-gsk.com/html/media-news/pressreleases/2012/2012-pressrelease-871338.htm GSK and Theravance announce initial outcomes from pivotal Phase III studies for once-daily RelovairTM* in COPD and asthma Mon, 09 Jan 2012 07:17:32 GMT http://www.us-gsk.com/html/media-news/pressreleases/2012/2012-pressrelease-840722.htm http://www.us-gsk.com/html/media-news/pressreleases/2012/2012-pressrelease-840722.htm GlaxoSmithKline provides update on divestment of non-core over-the-counter (OTC) brands Tue, 20 Dec 2011 13:32:07 GMT http://www.us-gsk.com/html/media-news/pressreleases/2011/2011-pressrelease-821659.htm http://www.us-gsk.com/html/media-news/pressreleases/2011/2011-pressrelease-821659.htm GSK extends pneumococcal vaccine agreement with GAVI Alliance Fri, 16 Dec 2011 12:10:27 GMT http://www.us-gsk.com/html/media-news/pressreleases/2011/2011-pressrelease-815420.htm http://www.us-gsk.com/html/media-news/pressreleases/2011/2011-pressrelease-815420.htm GlaxoSmithKline and Human Genome Sciences initiate phase III trial of belimumab (Benlysta®) administered subcutaneously in subjects with systemic lupus erythematosus Thu, 15 Dec 2011 12:59:41 GMT http://www.us-gsk.com/html/media-news/pressreleases/2011/2011-pressrelease-813237.htm http://www.us-gsk.com/html/media-news/pressreleases/2011/2011-pressrelease-813237.htm GSK presents phase lll data for lapatinib at San Antonio breast cancer symposium Thu, 08 Dec 2011 22:45:00 GMT http://www.us-gsk.com/html/media-news/pressreleases/2011/2011-pressrelease-798606.htm http://www.us-gsk.com/html/media-news/pressreleases/2011/2011-pressrelease-798606.htm GSK announces changes to the REMS program for PROMACTA® (eltrombopag) Tue, 06 Dec 2011 18:36:36 GMT http://www.us-gsk.com/html/media-news/pressreleases/2011/2011-pressrelease-792602.htm http://www.us-gsk.com/html/media-news/pressreleases/2011/2011-pressrelease-792602.htm Regulatory Update: GlaxoSmithKline submits additional information for candidate meningococcal and Hib combination vaccine Thu, 01 Dec 2011 14:15:51 GMT http://www.us-gsk.com/html/media-news/pressreleases/2011/2011-pressrelease-781656.htm http://www.us-gsk.com/html/media-news/pressreleases/2011/2011-pressrelease-781656.htm Reporting on a core earnings basis will begin with effect from Q1 2012 Thu, 01 Dec 2011 12:10:59 GMT http://www.us-gsk.com/html/media-news/pressreleases/2011/2011-pressrelease-781253.htm http://www.us-gsk.com/html/media-news/pressreleases/2011/2011-pressrelease-781253.htm GSK welcomes GAVI Alliance decision to introduce vaccines against cervical cancer and rubella in the world’s poorest countries Thu, 17 Nov 2011 12:48:09 GMT http://www.us-gsk.com/html/media-news/pressreleases/2011/2011-pressrelease-747646.htm http://www.us-gsk.com/html/media-news/pressreleases/2011/2011-pressrelease-747646.htm